Renal Dialysis Market at a CAGR of 8.50 % during forecasted period 2023-2030

Market Highlights

Global renal dialysis market in 2023 was USD 107.63 Billion. It is expected to grow at a CAGR of 8.50% and expected to reach USD 175.59 billion by end of 2030. Renal dialysis is process of detoxification. It is used to remove the toxics substance and excess of the water from the body. It is used when kidney is unable to perform its work. Global renal dialysis market is driven by increasing prevalence of renal diseases and different metabolic diseases. Beside this increasing aging population across the globe is the other factor providing fuel for the growth of the market. On other hand high cost associated with the diseases may responsible for restraining the market growth.

On regional basis, global renal dialysis market is dominated by North America. Increase in prevalence of renal diseases and a huge diabetic and obese population is responsible for the growth of renal dialysis market in North America. Europe and Asia Pacific are nearly similar market in terms of value but soon Asia Pacific is expected to overcome the European market for renal dialysis. Due to growing aging population and increasing renal disease in Asia Pacific region especially in Japan has boosted the growth of renal dialysis market in Asia Pacific region. Middle East and Africa has least market due to less growth of healthcare sector in that region.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Renal Dialysis Market Research Report

Segmentation:

Global renal dialysis market is segmented on the basis of types in primary dialysis and secondary dialysis. Primary dialysis is further sub segmented into hemodialysis, hemofiltration and peritoneal dialysis. Secondary dialysis is further sub segmented into hemodiafiltration and intestinal dialysis. On the basis of product this market is segmented as hemodialysis products and peritoneal dialysis products and on the basis of end user global renal dialysis market is segmented as hospital care and home care.

Competitive Analysis

The major key player for the global renal dialysis market are Baxter International Inc. (US), Fresenius Medical Care (German), DaVita Healthcare Partners Inc (US), B.Braun Melsungen AG (Germany), Medical Care AG & Co., Gambro AB (Sweden), Nipro diagnostic Inc. (US), Diaverum Deutschland GmbH (Germany), KGaA (Germany), Covidien (Ireland), Nikkiso Co. Ltd. (Japan), Asahi Kasei Corporation (Japan), NxStage Medical, Inc. (U.S.) and many more.

Due to increasing prevalence of kidney diseases globally many of the companies are in the race of inventing the better treatment for ureteral stents market. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market. The two major companies Fresenius Medical Care and Baxter International Inc. account around 65 % of total market share.

Fresenius Medical Care is a German company and the world’s largest provider of dialysis products and services. It is the one of the major companies for global renal dialysis market account around 35 % of total global renal dialysis market. This company has introduced the new fluids – bicaVera low calcium and bicaNova use to regulate the acid-base balance through a pure bicarbonate buffer. 4008B, 4008S haemodialysis machine, 5008/5008S therapy system, FX-class dialysers with Helixone membrane and Polysulfone dialysers are the famous dialysis machines and filters.

Baxter International Inc. is an American health care company primarily focuses on products to treatment of hemophilia, kidney disease and other metabolic diseases. AMIA Automated PD System, REVACLEAR, REVACLEAR 300, REVACLEAR Max Dialyzers, HOMECHOICE & HOMECHOICE PRO Automated PD Systems are the common products by the company. Baxter has acquired Gambro in 2013.